Camilio, K. A., Wang, M., Mauseth, B., Waagene, S., Kvalheim, G., Rekdal, Ø., . . . Mælandsmo, G. M. (2019). Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model. Breast Cancer Res.

Camilio, Ketil A., Meng-Yu Wang, Brynjar Mauseth, Stein Waagene, Gunnar Kvalheim, Øystein Rekdal, Baldur Sveinbjørnsson, e Gunhild M. Mælandsmo. "Combining the Oncolytic Peptide LTX-315 With Doxorubicin Demonstrates Therapeutic Potential in a Triple-negative Breast Cancer Model." Breast Cancer Res 2019.

Camilio, Ketil A., et al. "Combining the Oncolytic Peptide LTX-315 With Doxorubicin Demonstrates Therapeutic Potential in a Triple-negative Breast Cancer Model." Breast Cancer Res 2019.